CPD is an inflammatory skin disease with involvement of cytokines, of which some such as interleukin-31, utilize JAK/signal transducer and activator of transcription signalling.3,7,8 Therefore, one may hypothesize that JAK inhibitors are beneficial for the treatment of CPD, ameliorating not only inflammation, but also pain and itch. This evidence concerns the gene IL31 and inflammatory skin disease.